K-ras mutation in colorectal carcinomas from singapore

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Colorectal cancer (CRC) is a significant global health concern.
• The K-ras oncogene plays a critical role in cell signaling pathways implicated in cancer development.
• Understanding K-ras mutations in sporadic CRC is crucial for targeted therapies.

Purpose of the Study:

• To investigate the frequency and spectrum of K-ras oncogene mutations in sporadic colorectal cancers.
• To identify specific mutation types and their distribution within key codons (12, 13, and 61).
• To explore potential correlations between K-ras mutations and clinicopathological features of CRC.

Main Methods:

• Analysis of DNA from 54 sporadic colorectal cancer tissue samples.
• Utilized single-strand conformation polymorphism (SSCP) and direct sequencing to detect K-ras mutations.
• Focused on mutations within codons 12, 13, and 61 of the K-ras gene.

Main Results:

• Point mutations in the K-ras oncogene were identified in 48% (26/54) of the analyzed colorectal cancers.
• All detected mutations resulted in amino acid substitutions; no insertions or deletions were observed.
• The majority of mutations occurred at codon 13 (22/26), with a notable prevalence of Glycine to Serine substitutions (54% of all mutations).
• A single mutation was found at codon 61, and four at codon 12.
• G-->A transitions were the predominant mutation type.
• No significant correlation was found between K-ras mutations and tumor location, Dukes' stage, differentiation, patient age, or sex.

Conclusions:

• K-ras oncogene mutations are frequent in sporadic colorectal cancer, predominantly as missense mutations at codon 13.
• The specific (13)Gly-(13)Ser mutation is particularly common.
• K-ras mutation status in this cohort did not appear to be associated with key clinicopathological parameters.